Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Sponsor: Chris Goss
Summary
Sputum culture has been the best approach to detect harmful bacteria in the lungs of people with cystic fibrosis (CF). With the widespread use of new CF therapies (like Trikafta and Alyftrak), it is more difficult for people with CF to produce sputum even though they still have harmful bacteria in their lungs. The SEND-CF study is being done to see if there are other ways to detect harmful bacteria in the lungs.
Official title: Study to Enable New Diagnostics for Pulmonary Microbes in People With CF (SEND-CF)
Key Details
Gender
All
Age Range
16 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2026-02-01
Completion Date
2027-08-01
Last Updated
2025-12-31
Healthy Volunteers
No
Conditions
Locations (9)
University of California San Diego
La Jolla, California, United States
The Minnesota Cystic Fibrosis Center
Minneapolis, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Nationwide Children's Hospital
Columbus, Ohio, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
University of Texas Southwestern
Dallas, Texas, United States
Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, United States